e-learning
resources
Conferences
6th Sleep and Breathing Conference, Online 2021
2021
17.04.2021
COVID-19 and sleep
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Outcome of Nasal High Flow Nasal Oxygen Therapy (HFNO) in Acute Hypoxemic Respiratory Failure (AHRF) on an Acute Respiratory Care Unit (ARCU)
H. Elfaki (Wakefield, United Kingdom), E. Jenkinson (Wakefield, United Kingdom), E. Baron (Wakefield, United Kingdom), L. Jacob (Wakefield, United Kingdom), R. Carney (Wakefield, United Kingdom), M. Yousif (Wakefield, United Kingdom), A. Dwarakanath (Wakefield, United Kingdom)
Source:
Sleep and Breathing Conference 2021
Session:
COVID-19 and sleep
Session type:
Oral Presentation
Number:
0
Disease area:
Respiratory critical care
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Elfaki (Wakefield, United Kingdom), E. Jenkinson (Wakefield, United Kingdom), E. Baron (Wakefield, United Kingdom), L. Jacob (Wakefield, United Kingdom), R. Carney (Wakefield, United Kingdom), M. Yousif (Wakefield, United Kingdom), A. Dwarakanath (Wakefield, United Kingdom). Outcome of Nasal High Flow Nasal Oxygen Therapy (HFNO) in Acute Hypoxemic Respiratory Failure (AHRF) on an Acute Respiratory Care Unit (ARCU). Sleep and Breathing Conference 2021
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Impact of Dexamethasone on pathogen profile of COVID-19 patients requiring intensive care: a multicentre retrospective study
Optimizing invasive ventilation for SMA type 1 children who are receiving the gene therapy
Related content which might interest you:
Non-Invasive Respiratory Support outcomes in patients with SARS-Cov-2 and Respiratory Failure managed in an Acute Respiratory Care Unit (ARCU)
Source: Virtual Congress 2021 – Acute non-invasive respiratory therapies in COVID-19 and beyond
Year: 2021
Non Invasive Ventilation in Acute Respiratory Failure in Patients of Post Tubercular Bronchiectasis: Effectiveness and Predictors of Failure.
Source: International Congress 2017 – TB: co-morbidities and outcome
Year: 2017
Risk Factors for Mortality in Patients with Idiopathic Pulmonary Fibrosis Followed at Intensive Care Unit due to Acute Respiratory Failure
Source: International Congress 2018 – What is new in idiopathic interstitial pneumonias?
Year: 2018
HACOR in Action: Noninvasive Ventilation Failure in Acute Respiratory Failure
Source: Virtual Congress 2020 – Non-invasive ventilation and nasal high flow: technical aspects and predictive scores
Year: 2020
Lung surfactant, there is more to it than just surface tension
Source: International Congress 2014 – Neonatal and paediatric intensive care
Year: 2014
High Flow Nasal Therapy (HFNT) in Pediatric patients at the Home
Source: Virtual Congress 2020 – Non-invasive ventilation during acute and chronic respiratory failure: technical aspects, adherence and effects
Year: 2020
Risk Factor for Noninvasive Ventilation Failure in Influenza Infection with Acute Respiratory Failure in ED
Source: Respiratory Failure and Mechanical Ventilation Conference 2020
Year: 2020
Role Of Non Invasive Ventilation With Average Volume Assured Pressure Support (AVAPS)mode in patients with COPD and Type II Respiratory Failure
Source: International Congress 2019 – Treatment of chronic respiratory failure with noninvasive ventilation
Year: 2019
Association of the Estimated Dead Space Fraction and the Ventilatory Ratio with Mortality in Patients with Acute Respiratory Distress Syndrome
Source: International Congress 2019 – Acute respiratory distress syndrome: developments in diagnostics and outcomes
Year: 2019
Topic 3
Source: Respipedia Article
Year: 2017
Effects of nebulized heparin in a rat-model of endotoxemia-induced lung injury
Source: International Congress 2014 – Critical illness and therapeutic interventions
Year: 2014
Risk Factors and Clinical Impact of Fibrotic-Like Changes and the Organizing Pneumonia Pattern in Patients with COVID-19- and Non-COVID-19-induced Acute Respiratory Distress Syndrome.
Source: Virtual Congress 2021 – COVID-19 and acute respiratory failure
Year: 2021
Assessment of Noninvasive Ventilation in COPD patients requiring Respiratory Critical Care
Source: International Congress 2018 – Non-invasive ventilation for acute respiratory failure
Year: 2018
Lung recruitment maneuver with and without nebulized albuterol for acute lung injury
Source: International Congress 2014 – ARDS, skeletal muscles, physiology and weaning
Year: 2014
The Effect Of An Active Exercise Program Combined With Chest Physiotherapy On Pain Severity,Posture, Respiratory Function And Quality Of Life In Patients With Chronic Obstructive Pulmonary Disease.
Source: International Congress 2019 – Exercise and rehabilitation in patients with acute and chronic respiratory diseases
Year: 2019
Ventilatory Support for Chronic Respiratory Failure
Source: Eur Respir Rev 2009; 18: 306
Year: 2009
Feasibility of Measuring Neural Respiratory Drive in the Home Following Severe COPD Exacerbation
Source: International Congress 2019 – New insights into respiratory function testing
Year: 2019
Outcome of acute drug-induced pneumonias in ICU
Source: Annual Congress 2013 –Diffuse parenchymal lung disease II
Year: 2013
Ward-based Non-invasive ventilation (NIV) as Ceiling of Care in Acute Hypercapnic Respiratory Failure (AHRF)
Source: International Congress 2018 – Non-invasive ventilation for acute respiratory failure
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept